CDK ASSOCIATES, L.L.C.'s Net Worth
Estimate Recalculated Dec 3, 2025 07:32PM EST
Who is CDK ASSOCIATES, L.L.C.
CDK ASSOCIATES, L.L.C. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Strongbridge Biopharma plc, Kala Pharmaceuticals, Inc., Molecular Templates, Inc., and Celator Pharmaceuticals Inc.
SEC CIK
CDK ASSOCIATES, L.L.C.'s CIK is 0001576081
Past Insider Trading and Trends
2018 was CDK ASSOCIATES, L.L.C.'s most active year for acquiring shares with 15 total transactions. CDK ASSOCIATES, L.L.C.'s most active month to acquire stocks was the month of June. 2017 was CDK ASSOCIATES, L.L.C.'s most active year for disposing of shares, totalling 2 transactions. CDK ASSOCIATES, L.L.C.'s most active month to dispose stocks was the month of June. 2020 saw CDK ASSOCIATES, L.L.C. paying a total of $3,328,298.25 for 1,479,377 shares, this is the most they've acquired in one year. In 2021 CDK ASSOCIATES, L.L.C. cashed out on 10,280,682 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
